Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

Harris V., Holmes J., Gbinigie O., Rahman NM., Richards D., Hayward G., Dorward J., Lowe D., Standing J., Breuer J., Khoo S., Petrou S., Hood K., Ahmed H., Carson-Stevens A., Nguyen-Van-Tam J., Patel M., Saville B., Francis N., Thomas NBP., Evans P., Dobson M., Png ME., Lown M., van Hecke O., Jani B., Hart N., Butler D., Cureton L., Patil M., Andersson M., Coates M., Williams S., Bateman C., Davies J., Raymundo-Wood I., Ustianowski A., Yu L-M., Hobbs R., Little P., Butler C., Group PANORAMICTC.